Beactica Therapeutics logo

Beactica Therapeutics jobs and careers

Uppsala, Sweden

About Beactica Therapeutics

Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilitiesby applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.

Founded in 2006 by Per Källblad.

Founded
2006
Employees
11 to 50
Total funding
$2.3M
Headquarters
Uppsala

Leadership

The top of Beactica Therapeutics's org chart, with how many people report into each leader.

PKPhoto of Per Källblad

Per Källblad

Co-Founder and CEO

7 reports

KKPhoto of Konrad Koehler

Konrad Koehler

Head of Discovery

5 reports

JWPhoto of Johan Winquist

Johan Winquist

Head Of Operations